Ras and rac are each members of the superfamily of monomeric GTPases and both function as molecular switches to link cell-surface signals to intracellular responses. Using a novel assay of cellular proliferation called R-SAT TM (Receptor Selection and Ampli®cation Technology), we examined the roles of ras and rac in mediating the proliferative responses to a variety of cellsurface receptors. Activated, wild-type and dominantnegative mutants of rac and ras were tested for their eects on cellular proliferation either alone or in combination with receptors. Activated rac (rac Q61L, henceforth rac*) and ras (ras G12V, henceforth ras*) each induced strong proliferative responses. Dominantnegative rac (rac T17N, henceforth rac (7)) dramatically suppressed proliferative responses to G-protein coupled receptors (GPCR's) including the m5 muscarinic receptor and the a1B adrenergic receptor. In contrast, rac(7) had little or no eect upon responses to the tyrosine kinase receptor TrkC, and only partially suppressed responses to the Janus kinase (JAK/STAT) linked granulocyte macrophage colony stimulating factor (GM-CSF) receptor. Dominant-negative ras (ras T17N, henceforth ras(7)) blocked the proliferative responses to all of the tested receptors. Compared to rac(7) and ras(7), wild-type rac and ras had only modest eects on the tested receptors. Overall these results demonstrate that rac mediates the proliferative eects of G-protein coupled receptors through a pathway that is distinct from the proliferative signaling pathway utilized by tyrosine kinase linked and JAK-linked receptors.
Introduction
Rac and ras are each members of the superfamily of monomeric GTPases (Hall, 1990; 1994) . These GTPases function as molecular switches which are activated upon binding GTP, and become deactivated by hydrolyzing GTP to GDP. The monomeric GTPases can be constitutively activated by mutations which impair GTPase activity (Bourne et al., 1991; Lowy and Willumsen, 1993; Barbacid, 1987) , while dominant negative alleles can be created by mutations that render these proteins unable to bind GTP (Feig and Cooper, 1988) . The ras proteins regulate a wide variety of cellular processes including growth and dierentiation, and constitutively activated ras is oncogenic. The rac proteins control cytoskeletal assembly (Tapon and Hall, 1997) and the exchange factors that activate rac are also oncogenic (Hart et al., 1994; Horii et al., 1994; Cerione and Zheng 1996) implying that like ras, rac also regulates mitogenic signaling pathways.
Three distinct protein phosphorylation cascades have been described which mediate intracellular responses to extracellular signals (Denhardt, 1996) , including the MAP/ERK kinase cascade (Marshall, 1995; Davis, 1993) which is preferentially activated by mitogens and growth factors and the SAPK/JNK and/ or p38 kinase cascades which are preferentially activated by cytokines and cellular stress Derijard et al., 1994) . The MAP/ERK kinase cascade is linked to inputs from cell surface receptors by ras while rac and rac-related GTPases activate the SAPK/JNK pathway (Coso et al., 1995; Minden et al., 1995) .
The molecular links between cell surface receptors and intracellular kinase cascades is the subject of intensive research. The pathways utilized by growth factor receptors which have tyrosine kinase activity are currently the best understood (Schlessinger, 1993) . Upon ligand binding, the tyrosine kinase linked receptors dimerize, become autophosphorylated, and recruit signaling molecules including adaptor proteins such as Grb2 and Shc. This receptor/adaptor complex can then bind ras exchange factors which catalyze the exchange of GTP for GDP, leading to activation of ras which in turn activates a variety of cellular eectors including the MAP/ERK kinase cascade.
Cytokine receptors signal using a similar strategy (Ihle, 1995) . Ligand binding causes receptor aggregation which promotes association of the receptors with intracellular tyrosine kinases called JAKs (Janus kinases). The JAKs can then directly activate a family of transcription factors called STATs (Signal Transducers and Activators of Transcription). Thus, these receptors are also known as JAK/STAT linked receptors. The JAK/STAT receptors induce tyrosine phosphorylation of vav which has high homology to exchange factors that activate rac-related GTPases.
The JAK/STAT linked receptors also recruit many of the same signaling molecules the tyrosine kinase receptors utilize, and have been shown to activate ras.
Compared to the tyrosine-kinase and JAK/STAT linked receptors, less is known about the signaling pathways linking GPCR's to proliferative responses. GPCR's have been shown to stimulate the phosphorylation of both MAPK's and JNK's (Gardener et al., 1993; Coso et al., 1995b) , however it is not apparent which pathways are required by GPCR's to generate mitogenic signals, nor is it clear how they are linked to kinase cascades. We have developed a high throughput functional assay called R-SAT (Receptor Selection and Ampli®cation Technology, see Burstein et al., 1995) which measures proliferative responses of cultured cells. Using R-SAT, we have found that compared to other cell surface receptors, G-protein coupled receptors are selectively linked by rac to proliferative signaling pathways.
Results
G-protein coupled receptors (GPCR's), tyrosine kinase-linked receptors and JAK/STAT-linked receptors each activate intracellular kinase cascades, which in turn mediate complex cellular responses such as proliferation (Denhardt, 1996) . The monomeric GTPase ras plays a pivotal role in linking cell surface receptors to intracellular signaling pathways and recently it has become clear that the ras-related GTPase rac performs similar functions. We therefore tested activated, wild-type and dominant negative mutants of rac and ras for their eects on cellular proliferation either alone or in combination with receptors. As shown in Figure 1 , both rac and constitutively activated rac (rac*, see Materials and methods) induced signi®cant proliferative responses, amplifying cells up to threefold over control values. The response was dose-dependent, and was greater for rac* than rac. For comparison, wild-type and activated versions of the heterotrimeric G-protein Ga13, which is oncogenic (Dhanasekaran and Dermott, 1996; VoynoYasenetskaya et al., 1994) and is thought to regulate rac-dependent signaling pathways (Voyno-Yasenetskaya et al., 1996; Vara Prasad et al., 1995) , were also tested. Ga13* induced a response very similar in magnitude to rac*. As expected ras* induced very strong proliferative responses.
We next tested the eects of co-expressing wild-type and dominant negative versions of rac and ras upon the cellular responses induced by m5 muscarinic receptor. As shown in Figure 2 , NIH3T3 cells transfected with the m5 muscarinic receptor (Bonner NIH3T3 cells were transfected with the indicated amounts of Gprotein, 500 ng of b-galactosidase and sucient control vector to bring the total pool to 1 mg DNA. Transfected cells were cultured and assayed by R-SAT TM as described in the Materials and methods. Rac*, ras* and Ga13* are constitutively activated by mutations (to rac Q61L, ras G12V and Ga13 Q226L respectively) which impair their intrinsic GTPase activities (see Bourne et al., 1991) . Fold stimulation was calculated as the ratio of G-protein response to control response. Control transfections consisted of bgal and control vector Figure 2 Eects of ras and rac on proliferative responses to the m5 muscarinic receptor. NIH3T3 cells were transfected with 40 nanograms of receptor. 500 ng of b-galactosidase, 800 ng of Gprotein and sucient control vector to bring the total pool to 1.5 mg DNA. Transfected cells were cultured with the indicated concentrations of carbachol and assayed by R-SAT TM as described in Materials and methods. Rac(7) and ras(7) are each dominant negative mutants which contain the mutation T17N, rendering these proteins unable to bind GTP (see Feig and Cooper, 1988) et al., 1988) and b-galactosidase were ampli®ed in the presence of the muscarinic agonist carbachol compared with cells grown in the absence of ligand. Cotransfection of m5 with rac(7) markedly reduced the proliferative response observed at all tested concentrations of carbachol ( Figure 2 , Table 1 ). Similar results were obtained with ras(7). Co-transfection of m5 with wild-type rac did not block cellular responses to m5, and raised the baseline slightly, possibly due to direct stimulation of proliferation by rac itself. In all cases, the observed reductions in maximum response values were not accompanied by large changes in EC 50 values, suggesting the eects of rac (7) and ras (7) were distal and not directly at the receptor level. Radioligand binding studies indicated that co-expression of rac (7) had little or no eect on the expression of m5 receptors (2.9+0.3 fmol/mg for m5 versus 3.5+0.3 fmol/mg for m5 + rac (7)), thus the rac(7) induced blockade was not due to decreased expression of m5.
A number of other receptors were tested to examine whether or not the inhibitory eects of rac (7) and ras(7) were speci®c to G-protein coupled receptors. As shown in Figure 3 , NIH3T3 cells transfected with either the a1B adrenergic receptor (a GPCR, see Cotecchia et al., 1988) , the TrkC neurotrophin receptor (a tyrosine kinase receptor, see Tsoulfas et al., 1993) , or the granulocyte/macrophage colony stimulating factor receptor (GM-CSF, a JAK/STAT linked receptor, see Areces et al., 1993) were ampli®ed 6 to 8-fold in the presence of the appropriate agonist ligands compared with cells grown in the absence of ligand. Co-expression of rac (7) dramatically suppressed the proliferative response to the a1B adrenergic receptor, similar to results shown above for the m5 receptor. Strikingly, rac(7) had little or no eect on the response to the TrkC receptor, and a signi®cantly reduced eect on the GM-CSF receptor. Co-expression of ras (7) blocked the proliferative responses to all of the tested receptors. Wild-type rac had modest inhibitory eects on a1B and TrkC and a slight stimulatory eect on GM-CSF (see Table  1 ). Co-transfection of ras consistently raised the basal (ligand-free) response, but had little or no eect on the ligand-dependent responses of a1B and TrkC, though it paradoxically inhibited responses to GM-CSF.
To rule out the possibility that the dierential eects of rac (7) and ras(7) were due to transfection artifacts, or general eects on cellular viability, a1B and TrkC were co-transfected and assayed with rac, ras, rac(7), ras(7) or control vector (Figure 4 ). Virtually identical results were obtained for each receptor compared to the results when the receptors were tested separately. Again rac(7) markedly inhibited the a1B induced response but had little or no eect upon the TrkC induced response in the presence of their respective ligands. Similarly, the results obtained with the GM-CSF co-transfected with a1B receptor were essentially unchanged compared to the outcome when these receptors were tested separately (data not shown). Thus the selective eects of rac upon a1B-generated proliferative responses are not due to transfection artifacts or a general reduction of cellular viability.
The eects of varying the amount of G-protein, receptor, or ratio of receptor to G-protein were examined to quantify the eects of rac and ras upon receptor signaling (see Table 1 ). The rac-mediated and ras-mediated inhibition of a1B signaling was very similar across most of the doses tested. In each case, a twofold excess of the GTPase was sucient to achieve 70% inhibition suggesting that rac and ras do (7); open triangles, receptor + ras; ®lled triangles, receptor + ras(7). Rac(7) and ras(7) are each dominant negative mutants which contain the mutation T17N, rendering these proteins unable to bind GTP (see Feig and Cooper 1988) . (a) TrkC neurotrophin receptor assayed with the indicated concentrations of neurotrophin-3 (NT-3.) (b) Alpha 1B adrenergic receptor assayed with the indicated concentrations of phenylephrine. (c) Granulocyte macrophage colony stimulating factor receptor assayed with the indicated concentrations of granulocyte macrophage colony stimulating factor not dier greatly in their abilities to inhibit a1B. The amount of ras(7) required to achieve 50% inhibition of TrkC was at least twice what was needed to inhibit a1B, although the amount of ras needed to achieve over 80% inhibition was greater for a1B (800 ng) than for TrkC (400 ng). To investigate whether the inability of rac(7) to inhibit responses to TrkC was because the TrkC induced signal was inherently stronger than the a1B induced signal, the amount of TrkC transfected was reduced 20-fold and tested in the presence and absence of a 400-fold excess of rac(7). Under these conditions, the TrkC response was reduced to under half the a1B response (data not shown), yet rac(7) still had little or no eect upon TrkC signaling, whereas the same amount of ras completely suppressed the TrkC mediated signal (Table 1) . Thus the selective ability of rac(7) to suppress a1B induced signals is most likely because a1B utilizes a rac-dependent signal transduction pathway that is distinct from the pathway utilized by TrkC.
Discussion
We have demonstrated that G-protein coupled receptors are selectively linked by the ras-related GTPase rac to proliferative signaling pathways. Dominant negative rac selectively inhibits proliferative responses to the a1B adrenergic receptor and the m5 muscarinic receptor, which are G-protein coupled receptors, but does not block proliferative responses to the TrkC tyrosine kinase receptor, and only partially suppresses responses to the JAK/STAT linked GM-CSF receptor. Furthermore, rac itself stimulates proliferative responses.
The molecular links between G-protein coupled receptors and the kinase cascades are not currently understood but the proximal step is receptor catalyzed exchange of GTP for GDP followed by dissociation of the a-and bg-subunits of G-proteins (Rens-Domiano and Hamm, 1995). a-and bg-subunits each activate eector enzymes and each activates proliferative 
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Alpha1B+rac Alpha1B+rac(7) Alpha1B+rac(7) Alpha1B+rac(7) Alpha1B+rac(7) Alpha1B+rac(7) Alpha1B+rac(7) Alpha1B+ras Alpha1B+ras(7) Alpha1B+ras (7) Alpha1B+ras (7) Alpha1B+ras (7) Alpha1B+ras (7) Alpha1B+ras (7 (7) TrkC+ras (7) TrkC+ras (7) TrkC+ras (7) TrkC+ras (7) TrkC (2 ng) TrkC (2 ng)+rac (7) TrkC (2 ng)+ras (7) TrkC (5ng) TrkC (5ng)+rac (7) TrkC (5ng) Note: nd indicates could not be determined. NIH3T3 cells were transfected with forty nanograms of receptor (except where noted), 500 ng of bgalactosidase, the indicated amounts of G-protein and sucient control vector to bring the total pool to 1.5 mg DNA. Transfected cells were cultured and assayed by R-SAT TM as described in the Materials and methods. Responses to receptor/G-protein combinations were normalized to the responses of the individual receptors. EC 50 's of the receptor/G-protein combinations were divided by the EC 50 of the individual receptors to derive the EC 50 ratio. Values represent means of 2 ± 4 experiments. Rac(7) and ras(7) are each dominant negative mutants which contain the mutation T17N, rendering these proteins unable to bind GTP ( see Feig and Cooper 1988) pathways (Clapham and Neer, 1993) . The heterotrimeric G-proteins Gaq, Ga12 and Ga13 are each capable of transforming NIH3T3 cells (Dhanasekaran and Dermott, 1996; Voyno-Yasenetskaya et al., 1994; Chan et al., 1993; Xu et al., 1993; Jiang et al., 1993; Kalinec et al., 1992) and we have previously shown that Gaq but not Ga12 is responsible for transducing m5-induced proliferative responses in NIH3T3 cells (Burstein et al., 1995b; . It has been recently shown that GTPase de®cient mutants of Gaq, Ga12 and Ga13 activate the JNK pathway (VoynoYasenetskaya et al., 1996; Vara Prasad et al., 1995) and we have found that Gaq, Ga12 and Ga13 can each induce proliferative responses in R-SAT TM (Figure 1 and see Burstein et al., 1997) . Thus, although bg subunits have been implicated in MAP kinase pathway activation (Crespo et al., 1994) , the available evidence suggests that the Ga subunit probably transduces proliferative responses along the signaling pathway regulated by rac.
Both JunK and MAP kinase pathways have been implicated in transformation of 3T3 cells. The m1 muscarinic receptor, which transforms NIH3T3 cells in response to agonist stimulation (Gutkind et al., 1991) , has been shown to activate both the MAP kinase and Jun kinase cascades (Coso et al., 1995b) , which are each preferentially regulated by ras and rac, respectively (Denhardt, 1996; Coso et al., 1995; Minden et al., 1995) . The closely related m5 muscarinic receptor also transforms via a ras-dependent pathway (Mattingly et al., 1994) . Mutationally activated MEK is sucient for cellular transformation and tumorigenesis (Mansour et al., 1994; Cowley et al., 1994) , and Jun is required for transformation by ras (Smeal et al., 1991) , thus it is possible that either MAPK or JNK pathways, or both together are utilized to elicit mitogenic responses. The ser/thr kinase raf has been implicated in transformation by m1 receptors (Crespo et al., 1994b) , suggesting a MAPK mediated proliferative signal. MEKK1, which preferentially activates SEK of the JNK pathway but is capable of activating MEK (Yan et al., 1994; Minden et al., 1994) binds to ras (Russell et al., 1995) . Thus intersection of these distinct pathways may occur at the level of ras or MEKK to generate mitogenic responses. Consistent with these observations that both kinase cascades contribute to proliferative responses is the evidence that ras requires rac1 and other rac-related GTPases to fully transform cells (Khosravi-Far et al., 1995) .
It is likely that the dbl-related family of genes, including dbl, ost and vav (Cerione and Zheng, 1996) serve as molecular links immediately upstream of rac1 linking it to proliferative signals emanating from Gprotein coupled receptors. The dbl proteins are themselves oncogenic, stimulate JNK activation and many show exchange factor activity towards the racrelated GTPases (Hart et al., 1994; Horii et al., 1994; Cerione and Zheng, 1996; Denhardt, 1996) . Candidate molecules which could act upstream of these exchange factors include the src-like non-receptor tyrosine kinases, Pyk2 and the adaptor molecule shc (Dikic et al., 1996; Chen et al., 1996) . Deletion of the src-like kinases Lyn, Syk, Btk and Csk abolishes muscarinic receptor activation of the MAP kinase cascade in avian Figure 4 Multiplexed assay of the eects of ras and rac on proliferative responses to the Alpha 1B adrenergic receptor and the TrkC neurotrophin receptor. NIH3T3 cells were transfected and assayed as described for Figure 2 except that 40 ng of each receptor were cotransfected into the same dish of cells. Cells were trypsinized, divided and aliquoted into the wells of a 96-well rack as described in the Materials and methods and cultured in the presence of the indicated concentrations of either phenylephrine or neurotrophin-3 (NT-3). Control experiments have veri®ed that there is no cross-reactivity of either ligand with either receptor (data not shown) B lymphoma cells, while retransfection of the deleted genes restores responsiveness (Wan et al., 1996; . A direct connection between the IgE Fc (Fcepsilon) receptor and sequential activation of Syk, Vav, rac1 and the JNK pathway has recently been demonstrated (Teramoto et al., 1997) . Potential eectors operating immediately downstream from rac1 include the p21 activated kinase (PAK) which is stimulated upon binding GTP-loaded rac (Manser et al., 1994) . However numerous other eectors may also respond to rac1 (Tapon and Hall, 1997) and other targets besides PAK may connect rac1 to JNK activation (Gerwins et al., 1997; Teramoto et al., 1996; Burbelo et al., 1995) .
In conclusion, we have shown that the ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors. In addition, we have shown that tyrosine kinase linked receptors stimulate cellular proliferation through a pathway that is distinct from the pathway(s) regulated by rac1. Thus rac1 could operate upstream of ras to link GPCR's to a ras-regulated proliferative pathway that tyrosine kinase receptors access downstream of rac1. Alternatively GPCR's could stimulate two parallel pathways controlled by rac1 and ras respectively, which each contribute to generating a proliferative response. Such a scheme would explain the partial sensitivity of the GM-CSF receptor to racblockade. The possibility that rac1 operates downstream of ras appears less likely because in that case one would expect each class of receptor to be sensitive to rac-blockade as well as ras-blockade. Further work will be needed to elucidate all of the steps in the proliferative pathways used by G-protein coupled receptors.
Materials and methods

Cell culture
NIH3T3 cells (ATCC no. CRL 1658) were incubated at 378C in a humidi®ed atmosphere (5% CO 2 ) in Dulbecco's modi®ed Eagles medium supplemented with 4500 mg/l glucose, 4 mM L-glutamine, 50 U/ml penicillin G/streptomycin (A.B.I.) and 10% calf serum.
Functional assays
The Receptor Selection and Ampli®cation Technology (R-SAT TM ) assay is based on protocols previously used to evaluate induction of foci by ligand-occupied muscarinic receptors (Gutkind et al., 1991) . In this assay technology, ligands select and amplify cells that express functional receptors. The same cells express a reporter gene, thus the ampli®cation of these cells results in ampli®cation of the reporter enzyme. R-SAT assays were performed as described previously (Burstein et al., 1995) using 2 ± 200 ng receptor, 500 ng pSI-b-galactosidase (Promega, Madison WI), 50 ± 1000 ng G-protein, and sucient control vector to balance the total DNA pool. DNA was transfected into 2610 5 cells per well of a six-well plate. rac Q61L, ras G12V and Ga13 Q226L are constitutively activated by mutations which impair GTPase activity (see Bourne et al., 1991) and are referred to as rac*, ras* and Ga13*. rac T17N and ras T17N are dominant negative alleles each containing a mutation which abolishes GTPbinding but preserves GDP-binding (Feig and Cooper, 1988) and are referred to as rac (7) and ras(7). Previous experiments veri®ed that these constructs are expressed (Coso et al., 1995) . Cells were transfected by calcium precipitation, or using Lipofectamine (Gibco ± BRL) or Superfect (Qiagen) according to manufacturers instructions. One day after transfection media were changed and after another day cells were trypsinized and aliquoted into the wells of a 96-well plate (50 ml/well). One well of a 6-well plate yields enough cells for 24 wells. Cells were combined with ligands in DMEM supplemented with 2% cyto-SF3 synthetic supplement to a ®nal volume of 200 ml/ well (Kemp Laboratories). After 4 days in culture bgalactosidase levels were measured using 3.5 mM Onitrophenyl-b-D-galactopyranoside (Sigma, St Louis, MO) as the b-galactosidase substrate. Plates were read at 420 nm on a plate -reader (Bio-Tek EL 310 or Molecular Devices). Data from R-SAT assays were ®tted to the equation: R=A+B*x/(x+c) where A=minimum response, B=maximum response and c=EC 50 , x=concentration of ligand. Curves were generated by least-squares ®ts using the program KaleidaGraph TM (Abelbeck Software).
